PauseRX logo

PauseRX Review

Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.6/10

Best for: explicit 503A pharmacy and physician-network disclosure

6.6
★★★☆☆3.3/5

PauseRX scores highest on the strength of its clinical program — drug options and dosing support.

Semaglutide

$199/mo

Tirzepatide

$249/mo
Same price at every dose

What the monthly price covers

Medication

Included

Provider visits

Included

Shipping

Not disclosed

Lab work

Not disclosed

Coaching

Not disclosed

See plans →

No insurance neededVetted by our editors

Compare top-rated alternatives ↓

PauseRX is a nationwide compounded GLP-1 telehealth platform notable for its transparency: it names its 503A pharmacy partner (Strive Pharmacy in Gilbert, AZ), its physician network (Beluga Health), and publishes a full FDA compounded-medication disclaimer. Despite the name, it isn't menopause-specific. Compounded semaglutide is a flat $199/mo at all doses and tirzepatide starts at $249/mo, with brand Wegovy, Zepbound, and Foundayo also available.

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
BrandSemaglutideTirzepatideWegovyZepboundFoundayoLegitScript Verified503A Pharmacy

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

Vetted alternatives to PauseRX

7.9/ 10
Verified partner

Trimi Health

Best for: budget-conscious shoppers

★★★★☆4/5

Editorial score · methodology

$99/mosemaglutide
$125/motirzepatide
CompoundedSemaglutideTirzepatide
Get StartedRead full Trimi Health review →
7.7/ 10
Verified partner

Ro

Best for: broadest GLP-1 formulary including Foundayo on day-one of launch

★★★★☆3.9/5

Editorial score · methodology

$149/moorforglipron
BrandOrforglipron
Get StartedRead full Ro review →
8.0/ 10
Verified partner

ShedRx

Best for: mainstream telehealth GLP-1 access

★★★★☆4/5

Editorial score · methodology

$149/mosemaglutide
$199/motirzepatide
CompoundedSemaglutideTirzepatideOrforglipronGHK-Cu
Get StartedRead full ShedRx review →
PauseRX logo
3.3 / 5
Our editorial rating
Visit PauseRX →

from $199/mo · no insurance needed

PauseRX at a glance

Type
GLP-1 telehealth provider
Medications
Semaglutide, Tirzepatide, Wegovy, Zepbound
Starting price
$199/mo
Pricing model
Flat — dose increases don't raise the monthly price
What's included
Medication · Consult
FDA status
No FDA warning letter on record

How we scored PauseRX

Each dimension is scored algorithmically from PauseRX’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.

Value25%

6.5/10

At $199/mo, PauseRX runs about 18% above the $169 median for GLP-1 providers. Pricing is flat across doses, so there is no escalation markup as you titrate up.

Effectiveness25%

7.4/10

PauseRX offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes.

User Experience15%

6.7/10

Online intake and platform experience — consult included in the price; 8 platform features disclosed.

Trust & Safety15%

7.3/10

Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy.

Accessibility10%

5.4/10

PauseRX's exact state footprint isn't published — confirm coverage in your state before signing up.

Support10%

5.2/10

PauseRX provides standard clinician follow-up; no extended coaching or community program is disclosed.

6scored dimensions
637providers compared
100%verified against live provider sites
Value 25%Effectiveness 25%User Experience 15%Trust & Safety 15%Accessibility 10%Support 10%

Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →

How we verified this PauseRX review

Last checked August 2026
  • Confirmed current pricing across 2 dose/plan tiers
  • Confirmed what the monthly price does and doesn't include
  • Checked the FDA warning-letter database for enforcement actions
  • Walked the public intake/checkout flow on the provider's site

Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.

What we checked

Provider's own pricing page
$199–$249/mo across 2 dose/plan tiers — checked August 2026
State pharmacy licensing & LegitScript status
LegitScript Verified
FDA warning-letter register
No letter on file for this provider

What to expect when you sign up with PauseRX

We walked PauseRX’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)

  1. 1Take a quick assessment to find the right treatment.
  2. 2Schedule a video consultation with a licensed provider.
  3. 3Receive a personalized treatment plan.
  4. 4Order is fulfilled by a licensed pharmacy with tracking.
Price shown before you startLive video visit required
  • Prices shown before signup: personalized GLP-1 all doses $199, GLP-1/GIP starting at $249.
  • Secure, no-contact delivery with no signature required; tracking provided after shipment.
  • Shipping address can be changed via account login.
  • Returns & refund policy is linked but details not shown on the homepage.

PauseRX customer support

GLP-1 medications PauseRX offers

Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.

Pricing

Prices re-verified

All doses (flat)Compounded
$199/mo
semaglutide
Starting tierCompounded
$249/mo
tirzepatide

Ready to get started?

Plans and promotions change often — check PauseRX's current pricing and active discounts before you decide.

See PauseRX pricing →

What we like

  • Names its 503A pharmacy partner (Strive Pharmacy, Gilbert AZ) — buyers can look up its licensure themselves
  • Names its physician network (Beluga Health) — you can research the clinical platform handling your prescriptions
  • Publishes the FDA compounded-medication disclaimer
  • Corporate legal entity disclosed (PauseRX, Inc.) — uncommon for direct-to-consumer GLP-1 platforms
  • Flat $199 'all doses' compounded semaglutide pricing — no per-tier escalation
  • Billed at ship, not at order — lower upfront cash exposure
  • LegitScript badge displayed
  • Adjunct longevity products (NAD+, Glutathione, Sermorelin) for a broader wellness stack

Watch-outs

  • States served not listed — site claims nationwide, but you must contact support to confirm availability
  • Restrictive cancellation policy — orders can't be changed or canceled once submitted, and medications can't be returned
  • No named medical director (Beluga Health is the network, not a named MD)
  • LegitScript certification number not shown — badge only, so no direct lookup
  • Insurance not accepted — cash-pay only; HSA/FSA eligibility not confirmed
  • Corporate physical address not provided
  • Despite the 'Pause' name, not positioned as menopause-specific care
  • Brand Wegovy, Zepbound, and Foundayo are consultations only, not direct dispensing

PauseRX: a compounded GLP-1 platform that actually tells you who's behind it

Most direct-to-consumer GLP-1 sites hide the machinery. They take your money, ship you a vial, and never name the pharmacy that filled it or the doctors who signed off. PauseRX is built differently, and that's the whole reason to consider it. It plainly states its corporate entity (PauseRX, Inc.), names the pharmacy that compounds your medication (Strive Pharmacy in Gilbert, Arizona, with a street address and phone number), names the clinical network that handles prescribing (Beluga Health), and publishes the full FDA disclaimer about compounded drugs. That level of disclosure is genuinely uncommon, and it's the single best argument for trusting them with a cash-pay prescription.

One thing to clear up first: despite the name, PauseRX is not menopause care. The 'Pause' branding is misleading. It's a weight-loss-first platform built around compounded semaglutide and tirzepatide, with a few longevity add-ons bolted on.

How the pricing actually works

PauseRX uses flat, all-dose pricing for its flagship product — compounded semaglutide is $199 a month at every dose, with no escalation as you titrate up. That matters more than it sounds. Many compounded programs start cheap and then quietly raise your bill each time the doctor bumps your dose, so the price you sign up for isn't the price you pay in month four. PauseRX doesn't do that on semaglutide — what you pay at the lowest dose is what you pay at the highest.

For context, $199 sits a bit above the category median of $169, so this isn't the cheapest compounded option on the market. You're paying a small premium, and the transparency-and-disclosure story is what you're paying it for. Compounded tirzepatide is a separate, higher 'starting at' tier rather than a flat rate, so confirm your exact monthly cost for that one before you commit.

Two billing details are worth knowing up front:

  • You're billed when your medication ships, not when you order. That lowers your upfront cash exposure — useful if you want to start the intake process without an immediate charge.
  • Orders can't be changed or canceled once submitted, and nothing can be returned. Processing starts immediately. This is a strict, no-takebacks policy, so be sure before you click.

What you get, and how it's dispensed

The $199 plan bundles both the medication and the provider consultation — you're not paying a separate visit fee on top. The compounded semaglutide and tirzepatide are made by Strive Pharmacy, a 503A compounding pharmacy, and the telehealth model is mostly asynchronous, though some states may require a video or chat visit before a prescription is issued.

PauseRX also lists brand-name Wegovy, Zepbound, and Foundayo — but read the fine print here. Those are offered as *consultations only*, not direct dispensing. In other words, PauseRX will talk to you about brand options, but the value proposition is squarely the compounded medications it actually fills. If your goal is brand-name FDA-approved product shipped to your door, this isn't the cleanest path. There are also a handful of longevity extras — NAD+, Glutathione, Sermorelin — if you want a broader wellness stack, though those are tangential to the weight-loss core.

The transparency story — and the real gaps

Here's why the disclosure matters in practice: because PauseRX names Strive Pharmacy with a license-able address and names Beluga Health as the clinical platform, you can check up on both yourself. You don't have to take a faceless website's word for it — you can look up the pharmacy's standing and research the physician network yourself. For compounded GLP-1s, where quality control genuinely varies between operators, that's a real safety advantage. A LegitScript badge is displayed too.

But honest reviewing means naming what's missing, and a few things are:

  • No state-by-state coverage list. The site claims nationwide service, but doesn't publish which states it actually serves — you have to contact support to confirm you're eligible.
  • No named medical director. Beluga Health is the network, but there's no individual MD publicly accountable for the medical program.
  • The LegitScript badge has no visible certification number, so you can't directly look up the certification — you're trusting the badge image itself.
  • Cash-pay only. Insurance isn't accepted, and HSA/FSA eligibility isn't confirmed.
  • No corporate physical address for PauseRX, Inc. itself (the address shown belongs to the pharmacy).

Who should choose PauseRX — and who should skip it

Choose it if you want a compounded GLP-1 program from a company that's willing to show its work: named pharmacy, named clinical network, disclosed legal entity, and an upfront FDA disclaimer. The flat all-dose semaglutide price is a bonus, and billing-at-ship is friendly to your cash flow. If openness ranks above rock-bottom price, PauseRX earns a look.

Skip it if you need insurance to apply, if you want brand-name Wegovy or Zepbound actually shipped rather than just discussed, or if you need to confirm coverage in your state before committing time to an intake. The strict no-cancel, no-return policy also means impulse-shoppers and the price-sensitive should pause (no pun intended) and compare. And if you came expecting menopause-specific care, this isn't that.

Bottom line

PauseRX is a solidly-disclosed, mid-priced compounded GLP-1 platform whose standout feature is honesty about its own supply chain — Strive Pharmacy, Beluga Health, PauseRX, Inc., and a plain-English FDA disclaimer all on the record. The transparency is better than most peers. What holds it back is the un-listed state coverage, the badge-without-a-number, the missing named medical director, and that unusually rigid cancellation policy. Pin down your state eligibility and your exact tirzepatide price before you sign up, and read more about how we weigh these factors in our scoring methodology.

If you're weighing alternatives, Eden ($198/month) and HumeCare+ ($199/month) are among the closest options we track to PauseRX.

The Bottom Line

PauseRX scores highest on the strength of its clinical program — drug options and dosing support.

Score: 6.6/10Best for: explicit 503A pharmacy and physician-network disclosureFrom: $199/mo

Ready to start with PauseRX?

Starting at $199/month. See current pricing and start your free consultation.

PauseRX might not be your best fit if…

We rank editorially, so here’s where a different provider we track may serve you better.

  • If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
  • If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
  • If you want built-in coaching and behavior-change support, consider Ro.

Frequently Asked Questions

PauseRX is a nationwide compounded-GLP-1 telehealth platform notable for its transparency: it names its 503A pharmacy partner (Strive Pharmacy in Gilbert, AZ), its physician network (Beluga Health), and its corporate entity (PauseRX, Inc.), and it publishes the FDA compounded-medication disclaimer. Despite the name, it is not menopause-specific. A licensed clinician determines whether GLP-1 therapy is appropriate for you.
PauseRX offers compounded semaglutide at a flat $199 per month across all doses and compounded tirzepatide starting at $249 per month, and it also offers brand Wegovy, Zepbound, and Foundayo as consultations only rather than direct dispensing. The compounded products are not FDA-approved finished products. Which option fits you is a clinical decision made with your provider.
Compounded semaglutide is a flat $199 per month at all doses, with tirzepatide starting at $249 per month, and you are billed when the medication ships rather than at order, lowering upfront cash exposure. It also offers adjunct longevity products such as NAD+, glutathione, and sermorelin. Confirm current pricing directly with PauseRX before enrolling.
PauseRX describes itself as nationwide but does not publish a states-served list, so you must contact support to confirm availability in your state. Coverage can also depend on your clinician review. Confirm before enrolling.
PauseRX is cash-pay only and does not accept insurance; HSA/FSA eligibility is not confirmed. It displays a LegitScript badge, though the certification number is not shown for direct lookup. Confirm current payment terms directly with the provider.
PauseRX has a restrictive policy: once an order is submitted it cannot be changed or canceled, and medications cannot be returned. Because billing occurs at ship, understand the ordering and timing rules before you submit. Review the current cancellation and refund terms directly with the provider before enrolling.
Yes — PauseRX is a legitimate telehealth provider, and it's LegitScript-certified. Our editors independently verified its pricing and offering and scored it 6.6/10. As with any medication, consult a licensed clinician before starting.
We don't find any safety warnings on file (no FDA action). The concerns our review flags are mostly transparency-related: States served not listed — site claims nationwide, but you must contact support to confirm availability; Restrictive cancellation policy — orders can't be changed or canceled once submitted, and medications can't be returned; No named medical director (Beluga Health is the network, not a named MD); LegitScript certification number not shown — badge only, so no direct lookup. None are safety issues, but they're worth weighing before you sign up.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Sources

The primary regulatory filings and peer-reviewed studies cited throughout this PauseRX review:

Sources & methodology — as of October 2026
  1. 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
  2. 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
  3. 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
  4. 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
  5. 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
  6. 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
  7. 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  8. 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  9. 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
  10. 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
  11. 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
  12. 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.

See PauseRX's current pricing

Plans start at $199/month. Start your free consultation to check eligibility and today's price.